Jeffrey Hubbell

Jeffrey Hubbell

Departmental website:
https://pme.uchicago.edu/faculty/jeffrey-hubbell

A biomolecular engineer and entrepreneur, Jeffrey Hubbell develops materials for use in regenerative medicine and immunology. His research has led to tools and treatments, including nanoparticle vaccines and drug delivery systems, that combat diseases ranging from influenza and type 1 diabetes to tuberculosis and cancer. Prof. Hubbell has co-founded five companies, three of which are based on or related to research he directs at the University of Chicago. His companies create surgical sealants and tissue repair agents, and develop technologies to increase immunotolerance. Along with his associates, he holds 77 patents.

A member of the National Academy of Engineering, Prof. Hubbell is an elected fellow of Biomaterials Science and Engineering, the American Association for the Advancement of Science, and the American Institute of Medical and Biological Engineering. He is a former president of the Society for Biomaterials.

Hubbell Stories

‘Inverse vaccine’ shows potential to treat multiple sclerosis, other autoimmune diseases Illustration depicting vaccine

‘Inverse vaccine’ shows potential to treat multiple sclerosis, other autoimmune diseases

UChicago Pritzker Molecular Engineering research could yield treatments with fewer side effects

Transistor can adhere to internal organs like tape Ph.D. student Nan Li, first author of the new paper, holds up a sample of the adhesive transistor.

Transistor can adhere to internal organs like tape

UChicago researchers’ design makes stable, suture-free medical monitoring in body possible

Three UChicago faculty members elected to National Academy of Sciences in 2023 Yellow flowers bloom on a tree on the UChicago campus, with a building in a background

Three UChicago faculty members elected to National Academy of Sciences in 2023

UChicago to partner on new Chan Zuckerberg Initiative biomedical research hub CZ Biohub San Francisco Research Associate Shruthi Vijay Kumar works at the “zebrafish hotel” in the lab

UChicago to partner on new Chan Zuckerberg Initiative biomedical research hub

CZ Biohub Chicago to bring together leading institutions to tackle grand scientific challenges

Eight UChicago faculty elected to American Academy of Arts and Sciences University of Chicago campus aerial

Eight UChicago faculty elected to American Academy of Arts and Sciences

UChicago researchers find way to improve multiple sclerosis treatment MS Treatment

UChicago researchers find way to improve multiple sclerosis treatment

UChicago molecular engineers take innovative approaches to COVID-19 vaccine PME Lab

UChicago molecular engineers take innovative approaches to COVID-19 vaccine

Specialized molecules could boost vaccine performance

Breakthrough helps fight ‘cold’ tumors that don’t respond to immunotherapy Cold Tumor Therapy

Breakthrough helps fight ‘cold’ tumors that don’t respond to immunotherapy

Pritzker School of Molecular Engineering research shows promise for cancer treatments

Update on University of Chicago’s research for a Covid-19 vaccine Media citation image, WGN-TV, Apr. 23

Update on University of Chicago’s research for a Covid-19 vaccine


Chicago Immunoengineering Innovation Center launches to develop technologies to treat diseases Immunotherapy Center

Chicago Immunoengineering Innovation Center launches to develop technologies to treat diseases

Scientists at UChicago’s Pritzker School of Molecular Engineering to focus on cancer, COVID-19 and autoimmune disorders

CONTENT TYPE
Filter by content type